UBS Oncology Impact Fund L.P. 13D/13G Filings for MEI Pharma, Inc. (MEIP)

UBS Oncology Impact Fund L.P. 13D and 13G filings for MEI Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-09
4:04 pm
Sale		2022-12-3113GMEI Pharma, Inc.
MEIP		UBS Oncology Impact Fund L.P.0
0.000%		-506,893decrease
(Position Closed)		Filing
2021-02-16
08:32 am
Purchase		2020-12-3113GMEI Pharma, Inc.
MEIP		UBS Oncology Impact Fund L.P.506,893
9.000%		194,393increase
(+62.21%)		Filing